WHO WE ARE
ACCURACY THROUGH INNOVATION
PROGNOSIS BIOTECH ________
THE COMPANY
ProGnosis Biotech is an innovative Greek biotechnology company, focused on immunodiagnostic testing, established in 2011. Located in Larissa, Greece, our headquarters accommodate an advanced manufacturing facility and a state-of-the-art Research and Development laboratory. Our offices in Thessaloniki house our Exports, Sales, Technical and Marketing Teams, while our offices in Athens expand on our Research and Development department.
Our Expertise
At Prognosis Biotech, in addition to next-generation immunoassays, we also develop our own antibodies in-house. Through extensive R&D, we create accurate and reliable ELISA and Lateral Flow tests and export our products to a network of over 62 countries. As part of our commitment to serve you better, we have also established our direct offices in Italy, France, Spain, Serbia, Poland, China, and the USA.
OUR MISSION
Our mission at ProGnosis Biotech is clear: to provide innovative, accurate and simple testing solutions to the challenges presented in the food safety, hygiene monitoring & clinical diagnostics industries.
OUR VISION
Our vision is to be a leader in diagnostics by developing high-quality products and services.
ACCURACY THROUGH INNOVATION ________
is ProGnosis Biotech’s statement, fulfilled by the production of reliable and innovative immunodiagnostic tests.
As the regulation standards for food safety continue to change around the world, and threats to human health rapidly multiply, we will continue to focus on solutions that simplify testing while maintaining accuracy
